mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.04 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.04 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.04 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.04 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.05 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.05 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |